Detalles de la búsqueda
1.
A retrospective observational population-based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m2 in Ontario, Canada.
Diabetes Obes Metab
; 23(4): 916-928, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33319487
2.
CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice.
Diabetes Obes Metab
; 21(3): 691-699, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30393961
3.
The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity.
Purinergic Signal
; 10(2): 305-12, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24163005
4.
Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real-world genomic datasets.
Mol Oncol
; 17(2): 230-237, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36269676
5.
Prevalence, Treatment Patterns, and Outcomes of Individuals with EGFR Positive Metastatic Non-Small Cell Lung Cancer in a Canadian Real-World Setting: A Comparison of Exon 19 Deletion, L858R, and Exon 20 Insertion EGFR Mutation Carriers.
Curr Oncol
; 29(10): 7198-7208, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36290844
6.
Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection.
Am J Physiol Heart Circ Physiol
; 298(3): H771-7, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20035027
7.
Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry.
Protein Expr Purif
; 73(1): 1-9, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20399865
8.
CANadian CAnagliflozin REgistry: Patient-Reported Outcomes of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Canadian Clinical Practice.
Can J Diabetes
; 43(7): 464-471, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31133438
9.
Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge.
Life Sci
; 89(17-18): 621-30, 2011 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21872611
10.
Nucleoside transporter expression profiles in human cardiac tissue show striking individual variability with overall predominance of hENT1.
Eur J Pharm Sci
; 41(5): 685-91, 2010 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-20883780
11.
Physiology of nucleoside transporters: back to the future. . . .
Physiology (Bethesda)
; 23: 41-8, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18268364
12.
Inosine and equilibrative nucleoside transporter 2 contribute to hypoxic preconditioning in the murine cardiomyocyte HL-1 cell line.
Am J Physiol Heart Circ Physiol
; 294(6): H2687-92, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18424636
Resultados
1 -
12
de 12
1
Próxima >
>>